Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tobin W Juvenal Insider Profile
4 Followers
Tobin W Juvenal, CCO at Castle Biosciences, holds 49.09K shares in Castle Biosciences (Ticker: CSTL). Most recently, Tobin W Juvenal Bought $6,701 shares of Castle Biosciences on Jan 04, 2024 for an estimated value of 19.38K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+2.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Tobin W Juvenal's holdings
Insider Roles
CCO
Roles that Tobin W Juvenal holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tobin W Juvenal
Tobin W Juvenal's Trading History
List of latest transactions for each holding click on a transaction to see Tobin W Juvenal's performance on stock
You May Also Like
Tobin W Juvenal insider profile FAQ
What is the percentage of profitable transactions made by Tobin W Juvenal?
The percentage of profitable transactions made by Tobin W Juvenal is 50%.
What is the average return per transaction made by Tobin W Juvenal?
The average return per transaction made by Tobin W Juvenal is 2.20%.
What stocks does Tobin W Juvenal hold?
Tobin W Juvenal holds: CSTL stocks.
What was Tobin W Juvenal’s latest transaction?
Tobin W Juvenal latest transaction was an Informative Buy of $19.38K.
What was Tobin W Juvenal's most profitable transaction?
Tobin W Juvenal’s most profitable transaction was an Informative Buy of CSTL stock on January 4, 2024. The return on the trade was 19.70%.
What is Tobin W Juvenal's role in Castle Biosciences?
Tobin W Juvenal's role in Castle Biosciences is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.